BioVU Archive — Page 7 of 8
-
November 16, 2017
Study may point to new treatment approach for ASD
Using sophisticated genome mining and gene manipulation techniques, researchers at Vanderbilt University Medical Center (VUMC) have solved a mystery that could lead to a new treatment approach for autism spectrum disorder (ASD). -
February 23, 2017
BioVU anniversary
Last week the BioVU Operations Oversight Board celebrated the 10-year anniversary of the launching of BioVU, Vanderbilt University Medical Center’s massive biobank. -
October 7, 2016
Rheumatoid subtypes explored by PheWAS
A computer-based method pioneered at Vanderbilt is being used to compare subtypes of rheumatoid arthritis. -
July 7, 2016
VUMC chosen for leadership role in NIH Precision Medicine Initiative Cohort Program
Vanderbilt University Medical Center has been chosen by the National Institutes of Health to be a leader in a landmark study of genetic, environmental and lifestyle factors affecting the health of a million or more people. The NIH will provide $71.6 million over five years to VUMC, making this the largest research grant the Medical Center has ever received from any source. -
July 7, 2016
VUMC chosen for leadership role in NIH Precision Medicine Initiative Cohort Program
Vanderbilt University Medical Center (VUMC) has been chosen by the National Institutes of Health (NIH) to be the Data and Research Support Center for the Precision Medicine Initiative Cohort Program, a landmark study of genetic, environmental and lifestyle factors affecting the health of a million or more people, federal officials have announced. -
April 4, 2016
VUMC and Celgene Corporation enter into research agreement to accelerate development of next-generation therapeutics
Vanderbilt University Medical Center has entered into a strategic research agreement with Celgene Corporation, a biopharmaceutical company based in Summit, New Jersey. -
December 10, 2015
Genetics Institute director Cox set for next Discovery Lecture
Nancy Cox, Ph.D., founding director of the Vanderbilt Genetics Institute, will deliver the next Flexner Discovery Lecture on Thursday, Dec. 17.